| SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants F Tea, A Ospina Stella, A Aggarwal, D Ross Darley, D Pilli, D Vitale, ... PLoS medicine 18 (7), e1003656, 2021 | 117 | 2021 |
| Mobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cells A Aggarwal, TL Iemma, I Shih, TP Newsome, S McAllery, AL Cunningham, ... PLoS pathogens 8 (6), e1002762, 2012 | 117 | 2012 |
| Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis CL Marquez, D Lau, J Walsh, V Shah, C McGuinness, A Wong, ... Elife 7, e34772, 2018 | 104 | 2018 |
| Herpes simplex virus utilizes the large secretory vesicle pathway for anterograde transport of tegument and envelope proteins and for viral exocytosis from growth cones of … M Miranda-Saksena, RA Boadle, A Aggarwal, B Tijono, FJ Rixon, ... Journal of virology 83 (7), 3187-3199, 2009 | 104 | 2009 |
| SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, A Akerman, V Milogiannakis, MR Silva, G Walker, AO Stella, ... EBioMedicine 84, 2022 | 78 | 2022 |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ... Cell reports Medicine 2 (4), 2021 | 74 | 2021 |
| Ultrastructural visualization of individual tegument protein dissociation during entry of herpes simplex virus 1 into human and rat dorsal root ganglion neurons A Aggarwal, M Miranda-Saksena, RA Boadle, BJ Kelly, RJ Diefenbach, ... Journal of virology 86 (11), 6123-6137, 2012 | 66 | 2012 |
| SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, AO Stella, G Walker, A Akerman, V Milogiannakis, F Brilot, ... medrxiv, 2021.12. 14.21267772, 2021 | 63 | 2021 |
| Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection NS Eyre, GN Fiches, AL Aloia, KJ Helbig, EM McCartney, CSP McErlean, ... Journal of virology 88 (7), 3636-3652, 2014 | 59 | 2014 |
| A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection C Counoupas, MD Johansen, AO Stella, DH Nguyen, AL Ferguson, ... npj Vaccines 6 (1), 143, 2021 | 49 | 2021 |
| Potent anti-SARS-CoV-2 activity by the natural product gallinamide A and analogues via inhibition of cathepsin L AS Ashhurst, AH Tang, P Fajtová, MC Yoon, A Aggarwal, MJ Bedding, ... Journal of medicinal chemistry 65 (4), 2956-2970, 2021 | 48 | 2021 |
| A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae PM George, A Reed, SR Desai, A Devaraj, TS Faiez, S Laverty, A Kanwal, ... Science translational medicine 14 (671), eabo5795, 2022 | 47 | 2022 |
| Discovery of cyclic peptide ligands to the SARS-CoV-2 spike protein using mRNA display A Norman, C Franck, M Christie, PME Hawkins, K Patel, AS Ashhurst, ... ACS Central Science 7 (6), 1001-1008, 2021 | 45 | 2021 |
| Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability DL Burnett, KJL Jackson, DB Langley, A Aggarwal, AO Stella, ... Immunity 54 (12), 2908-2921. e6, 2021 | 43 | 2021 |
| Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses H Balachandran, C Phetsouphanh, D Agapiou, A Adhikari, C Rodrigo, ... Cell reports 38 (6), 2022 | 38 | 2022 |
| Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing D Van Bockel, CML Munier, S Turville, SG Badman, G Walker, AO Stella, ... Viruses 12 (11), 1208, 2020 | 38 | 2020 |
| Antiviral cyclic peptides targeting the main protease of SARS-CoV-2 J Johansen-Leete, S Ullrich, SE Fry, R Frkic, MJ Bedding, A Aggarwal, ... Chemical science 13 (13), 3826-3836, 2022 | 36 | 2022 |
| Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia A Aggarwal, AO Stella, G Walker, A Akerman, C Esneau, V Milogiannakis, ... Nature Microbiology 7 (6), 896-908, 2022 | 31 | 2022 |
| Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes S Stelzer-Braid, GJ Walker, A Aggarwal, SR Isaacs, M Yeang, Z Naing, ... Pathology 52 (7), 760-763, 2020 | 29 | 2020 |
| SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents P Garcia-Valtanen, CM Hope, MG Masavuli, AEL Yeow, H Balachandran, ... Cell Reports Medicine 3 (6), 2022 | 28 | 2022 |
